secwatch.observer — SEC 8-K summary
======================================

Issuer:     OCULAR THERAPEUTIX, INC (OCUL)
CIK:        0001393434
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001104659-23-072258
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocular Therapeutix shareholders approve 3.9M share increase under 2021 Stock Incentive Plan
--------------------------------------------------------------------------------

- Approved Amendment No. 2 increasing shares under 2021 Stock Incentive Plan by 3.9M (29.4M for, 8.0M against).
- Elected Jeffrey S. Heier, M.D. and Merilee Raines as Class III directors until 2026 annual meeting.
- Ratified PricewaterhouseCoopers as independent auditor for FY 2023 (60.5M for, 43K against).
- Non-binding advisory vote on named executive officer compensation passed (26.5M for, 11.2M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1393434/000110465923072258/0001104659-23-072258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1393434/000110465923072258/tm2318782d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-072258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer